Bone metastasis of breast cancer
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Aged >=18 and <=75 2. Diagnosed with breast cancer and concomitant bone metastases from breast cancer 3. TCM syndrome pattern consistent with "liver and kidney deficiency" 4. ECOG performance status = 3 5. Willing to accept the treatment protocol of this study
Exclusion criteria
Exclusion criteria: 1. Those with severe cardiovascular and cerebrovascular diseases, liver and kidney dysfunction, or hematological disorders. 2. Those with a history of other tumors. 3. Those with mental disorders who cannot cooperate with the trial. 4. Those who have participated in other clinical trials within the past three months.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Objective response rate; | — |
Secondary
| Measure | Time frame |
|---|---|
| Disease control rate;Bone metabolism markers (osteocalcin, 25-hydroxyvitamin D, ß-collagen specific sequence, total type I collagen amino-terminal extension peptide determination);Bone density test;Expression of SOCS3 in peripheral blood and methylation level of SOCS3;Serum alkaline phosphatase (ALP) in peripheral blood, albumin-to-alkaline phosphatase ratio (AAPR), red cell distribution width (RDW), neutrophil-to-lymphocyte ratio (NLR) in peripheral blood, and carbohydrate antigen 15-3 (CA15-3);Traditional Chinese Medicine symptom and sign scoring;Pain assessment;Quality of Life Assessment; | — |
Countries
China
Contacts
Longhua Hospital Shanghai University of Traditional Chinese Medicine